BIOA-B.ST
BioArctic AB (publ)
StockholmSEKEQUITY
DELAYED
Last price
335.60
▼ 1.60 (0.47%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
336.20
Prev close
337.20
Day high
339.00
Day low
330.80
Volume
100.37K
Market cap
—
P/E (TTM)
—
52W range
235.00 – 364.40
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+5.01%
+6.4%
1M
+9.39%
+5.7%
3M
+0.54%
-2.6%
6M
-3.73%
-14.8%
YTD
+7.98%
-4.3%
1Y
+42.44%
+22.4%
3Y
+3.90%
-70.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.00B | $257.35M | $616.00M | $228.29M | — | +676.8% |
| Operating revenue | $2.00B | $257.35M | $616.00M | $228.29M | — | +676.8% |
| Cost of revenue | $59.22M | $26.98M | $14.99M | $74.33M | — | +119.4% |
| Gross profit | $1.94B | $230.37M | $601.01M | $153.97M | — | +742.1% |
| Research & development | $376.92M | $311.14M | $172.13M | — | — | +21.1% |
| Selling, general & admin | $194.83M | $148.84M | $172.18M | — | $24.85M | +30.9% |
| Total operating expense | $571.65M | $459.99M | $344.05M | $161.90M | — | +24.3% |
| Operating income | $1.37B | -$229.62M | $256.96M | -$7.94M | — | +695.9% |
| Net interest income | $32.33M | $40.84M | $33.85M | $1.78M | — | -20.8% |
| Pre-tax income | $1.26B | -$189.52M | $276.49M | -$11.17M | — | +762.5% |
| Tax provision | $233.26M | -$12.44M | $47.24M | $11.00K | — | +1,975.1% |
| Net income | $1.02B | -$177.08M | $229.25M | -$11.18M | — | +677.3% |
| Net income to common | $1.02B | -$177.08M | $229.25M | -$11.18M | — | +677.3% |
| Basic EPS | 11.55 | -2.00 | 2.60 | -0.13 | — | +677.5% |
| Diluted EPS | 11.52 | -2.00 | 2.59 | -0.13 | — | +676.0% |
| EBIT | $1.26B | -$189.52M | $276.81M | -$10.61M | — | +763.6% |
| EBITDA | $1.27B | -$178.80M | $284.25M | $4.03M | — | +810.5% |
| Basic shares | 88.55M | 88.35M | 88.23M | 88.07M | — | +0.2% |
| Diluted shares | 88.72M | 88.52M | 88.49M | 88.68M | — | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.04B | $512.93M | $611.57M | $805.39M | +102.8% |
| Cash & short-term investments | $2.19B | $778.92M | $1.11B | $805.39M | +181.2% |
| Accounts receivable | $121.65M | $71.20M | $223.00K | $0 | +70.9% |
| Total current assets | $2.49B | $1.01B | $1.15B | $820.84M | +146.1% |
| Property, plant & equipment | $82.99M | $96.62M | $31.13M | $35.26M | -14.1% |
| Total assets | $2.58B | $1.11B | $1.19B | $858.31M | +131.7% |
| Total current liabilities | $520.78M | $175.66M | $124.97M | $70.88M | +196.5% |
| Total debt | $44.07M | $54.23M | $4.98M | $10.04M | -18.7% |
| Total liabilities | $608.14M | $216.74M | $139.50M | $72.06M | +180.6% |
| Retained earnings | $1.35B | $305.07M | $462.87M | $217.52M | +343.0% |
| Shareholder equity | $1.97B | $894.94M | $1.05B | $786.24M | +119.8% |
| Working capital | $1.97B | $835.00M | $1.03B | $749.96M | +135.5% |
| Net tangible assets | $1.97B | $894.94M | $1.05B | $786.24M | +119.8% |
| Shares issued | 88.64M | 88.39M | 88.31M | 88.13M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.26B | -$228.51M | $252.64M | -$17.34M | +650.9% |
| Depreciation & amortisation | $12.83M | $10.72M | $7.44M | $14.18M | +19.7% |
| Stock-based compensation | $24.04M | $19.33M | $16.14M | $2.76M | +24.4% |
| Change in working capital | $174.22M | -$147.91M | $13.15M | $24.91M | +217.8% |
| Operating cash flow | $1.43B | -$316.33M | $309.69M | -$31.64M | +552.4% |
| Capital expenditure | -$10.24M | -$26.64M | -$7.44M | -$12.75M | +61.5% |
| Investing cash flow | -$894.65M | $205.63M | -$507.49M | -$12.76M | -535.1% |
| Financing cash flow | $26.90M | $5.69M | $14.06M | -$2.81M | +373.2% |
| Free cash flow | $1.42B | -$342.97M | $302.25M | -$44.38M | +514.3% |
| End cash position | $1.04B | $512.93M | $611.57M | $805.39M | +102.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $437.58M | $184.04M | $133.34M | $392.12M | $1.29B | +137.8% |
| Operating revenue | $437.58M | $184.04M | $133.34M | $392.12M | $1.29B | +137.8% |
| Cost of revenue | $19.54M | $15.06M | $12.22M | $20.49M | $11.44M | +29.8% |
| Gross profit | $418.04M | $168.97M | $121.13M | $371.63M | $1.28B | +147.4% |
| Research & development | $151.27M | $84.85M | $95.52M | $111.92M | $84.63M | +78.3% |
| Selling, general & admin | $52.40M | $49.45M | $50.34M | $49.05M | $46.00M | +6.0% |
| Total operating expense | $207.23M | $135.74M | $149.89M | $192.56M | $202.90M | +52.7% |
| Operating income | $210.81M | $33.24M | -$28.77M | $179.07M | $1.08B | +534.2% |
| Net interest income | $13.31M | $5.83M | $7.83M | -$7.60M | -$9.29M | +128.3% |
| Pre-tax income | $224.12M | $39.07M | -$20.94M | $171.48M | $1.07B | +473.6% |
| Tax provision | $11.73M | $47.90M | $65.93M | $74.93M | $44.51M | -75.5% |
| Net income | $212.39M | -$8.83M | -$86.87M | $96.55M | $1.02B | +2,505.9% |
| Net income to common | $212.39M | -$8.83M | -$86.87M | $96.55M | $1.02B | +2,505.9% |
| Basic EPS | 2.40 | -0.10 | -0.98 | 1.09 | 11.55 | +2,500.0% |
| Diluted EPS | 2.39 | -0.10 | -0.98 | 1.09 | 11.53 | +2,490.0% |
| EBIT | $224.65M | $44.00M | -$18.27M | $187.55M | $1.08B | +410.5% |
| EBITDA | $224.65M | $44.00M | -$18.27M | $187.55M | $1.08B | +410.5% |
| Basic shares | 88.64M | 88.64M | 88.58M | 88.53M | 88.46M | +0.0% |
| Diluted shares | 88.87M | 88.64M | 88.58M | 88.53M | 88.59M | +0.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.20B | $1.04B | $1.10B | $948.14M | $558.57M | — | +15.8% |
| Cash & short-term investments | $2.03B | $2.19B | $1.88B | $1.92B | $788.57M | — | -7.1% |
| Accounts receivable | — | $121.65M | — | — | — | $71.20M | — |
| Total current assets | $2.60B | $2.49B | $2.51B | $2.23B | $2.03B | — | +4.4% |
| Property, plant & equipment | $77.63M | $82.99M | $88.11M | $90.08M | $90.75M | — | -6.5% |
| Total assets | $2.68B | $2.58B | $2.60B | $2.33B | $2.12B | — | +4.0% |
| Total current liabilities | $397.15M | $520.78M | $600.03M | $259.03M | $151.47M | — | -23.7% |
| Total debt | $40.74M | $44.07M | $46.56M | $48.99M | $50.99M | — | -7.6% |
| Total liabilities | $481.21M | $608.14M | $631.81M | $293.59M | $189.15M | — | -20.9% |
| Retained earnings | — | $1.35B | — | — | — | $305.07M | — |
| Shareholder equity | $2.20B | $1.97B | $1.97B | $2.04B | $1.93B | — | +11.7% |
| Working capital | $2.20B | $1.97B | $1.91B | $1.98B | $1.88B | — | +11.9% |
| Net tangible assets | $2.20B | $1.97B | $1.97B | $2.04B | $1.93B | — | +11.7% |
| Shares issued | 88.72M | 88.64M | 88.64M | 88.53M | 88.53M | — | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $210.81M | $33.24M | -$28.77M | $179.07M | $1.08B | +534.2% |
| Change in working capital | -$214.41M | $273.67M | -$27.65M | $1.04B | -$1.11B | -178.3% |
| Operating cash flow | -$166.00M | $313.33M | -$41.19M | $1.15B | $11.79M | -153.0% |
| Investing cash flow | $319.41M | -$373.59M | $186.62M | -$742.91M | $35.23M | +185.5% |
| Financing cash flow | $10.73M | $627.00K | $13.15M | $674.00K | $12.45M | +1,611.0% |
| Free cash flow | -$166.00M | $313.33M | -$41.19M | $1.15B | $11.79M | -153.0% |
| End cash position | $1.20B | $1.04B | $1.10B | $948.14M | $558.57M | +15.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
326.34
+2.84% from price
SMA 20
321.91
+4.25% from price
SMA 50
316.03
+6.19% from price
SMA 100
319.04
+5.19% from price
SMA 200
314.56
+6.69% from price
EMA 12
326.05
+2.93% from price
EMA 26
321.42
+4.41% from price
EMA 50
318.88
+5.24% from price
RSI (14)
62.7
Neutral
MACD (12,26,9)
4.63
Hist 1.84
ATR (14)
9.11
2.72% of price
Realised vol 30D
25.7%
Annualised
Bollinger upper
336.59
20, 2σ
Bollinger lower
307.23
20, 2σ
50 / 200 cross
Golden
316.03 vs 314.56
Trend bias
Above 200
+6.69%
Risk profile
Beta vs SPY
0.16
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
25.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.9%
Peak to trough
Max drawdown 5Y
-63.0%
Peak to trough
ATR 14
9.11
2.72% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
International Strength Offsetting North America Weakness Could Be A Game Changer For Under Armour (UAA)
Simply Wall St. · 5m ago
Jim Cramer Argued It’s A New World For Palo Alto Networks & CrowdStrike Holdings
Insider Monkey · 10m ago
Newmont (NEM) Stock Looks Near Fair Value After A Strong Run
Simply Wall St. · 11m ago
Will Pega’s Free Responsible AI Tools Deepen Its Recurring Revenue Moat For Investors In PEGA?
Simply Wall St. · 11m ago
Jim Cramer Dismissed Market Reaction To Cisco Systems, Inc. (NASDAQ:CSCO) Following Earnings
Insider Monkey · 13m ago
Jim Cramer Doesn’t Think Home Depot Is Expensive Enough To Be Avoided
Insider Monkey · 19m ago
Jim Cramer Advised Being Patient & Buying Walmart Inc. (NASDAQ:WMT)’s Shares
Insider Monkey · 20m ago
Jim Cramer Discussed Ross Stores, Inc. (NASDAQ:ROST) & TJX
Insider Monkey · 21m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.